Current Bioactive Compounds

Editor-in-Chief

Adriano Mollica
Department of Pharmacy, University ”G. d' Annunzio” of Chieti-Pescara
Via dei Vestini 31
Chieti, 66100
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Editorial (Thematic Issue: New Advances of Drug Design in Cancer Disease Part I) free to download

Volume:10   Issue: 2
Pp: 75-75
Carlton A. Taft
DOI: 10.2174/157340721002141001102408
Published on: 30 September, 2014

Dietary Polyphenols for Prostate Cancer Therapy

Volume:10   Issue: 2
Pp: 76-111
Yan A. Ivanenkov, Nina V. Chufarova, Mark S. Veselov and Alexander G. Majouga
DOI: 10.2174/157340721002141001102524
Published on: 30 September, 2014


Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

Volume:10   Issue: 2
Pp: 112-123
Jonathan R. de Almeida, Josiana G. de Araujo Volpini, Joao G.C. Poiani, Carlton A. Taft and Carlos H.T. de Paula da Silva
DOI: 10.2174/157340721002141001102743
Published on: 30 September, 2014


The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development

Volume:10   Issue: 2
Pp: 124-130
Shaoyu Chang, Bela Torok and Kimberly A. Stieglitz
DOI: 10.2174/157340721002141001103101
Published on: 30 September, 2014


Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

Volume:10   Issue: 2
Pp: 131-138
Josiana G. de Araujo Volpini, Ricardo P. Rodrigues, Leonardo B. Federico and Carlos H.T. de Paula da Silva
DOI: 10.2174/157340721002141001103308
Published on: 30 September, 2014